However, anti-TNF therapy has not been associated with increases in SARS-CoV-2 replication or COVID-19 severity (100, 112), suggesting that TNF has minimal anti-viral activity against SARS-CoV-2 during COVID-19. This evidence concerns the gene TNF and COVID-19.